Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates.

Saved in:
Bibliographic Details
Title: Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates.
Authors: Spring, Bryan Q.1, Abu-Yousif, Adnan O.1, Palanisami, Akilan1, Rizvi, Imran1, Xiang Zheng1, Zhiming Mai1, Anbil, Sriram1, Sears, R. Bryan1, Mensah, Lawrence B.1, Goldschmidt, Ruth1, Erdem, S. Sibel1, Oliva, Esther2, Hasan, Tayyaba1,3,4 thasan@mgh.harvard.edu
Source: Proceedings of the National Academy of Sciences of the United States of America. 3/11/2014, Vol. 111 Issue 10, pE933-E942. 10p.
Subjects: Cancer treatment, Metastasis, Antibody-toxin conjugates, Cancer cells, Chromophores, Fluorescence microscopy
Abstract: Drug-resistant micrometastases that escape standard therapies often go undetected until the emergence of lethal recurrent disease. Here, we show that it is possible to treat microscopic tumors selectively using an activatable immunoconjugate. The immunoconjugate is composed of self-quenching, near-infrared chromophores loaded onto a cancer cell-targeting antibody. Chromophore phototoxicity and fluorescence are activated by lysosomal proteolysis, and light, after cancer cell internalization, enabling tumor-confined photocytotoxicity and resolution of individual micrometastases. This unique approach not only introduces a therapeutic strategy to help destroy residual drug-resistant cells but also provides a sensitive imaging method to monitor micrometastatic disease in common sites of recurrence. Using fluorescence microendoscopy to monitor immunoconjugate activation and micrometastatic disease, we demonstrate these concepts of "tumor-targeted, activatable photoimmunotherapy" in a mouse model of peritoneal carcinomatosis. By introducing targeted activation to enhance tumor selectively in complex anatomical sites, this study offers prospects for catching early recurrent micrometastases and for treating occult disease. [ABSTRACT FROM AUTHOR]
Copyright of Proceedings of the National Academy of Sciences of the United States of America is the property of National Academy of Sciences and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
FullText Text:
  Availability: 0
Header DbId: egs
DbLabel: Engineering Source
An: 94925778
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Spring%2C+Bryan+Q%2E%22">Spring, Bryan Q.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Abu-Yousif%2C+Adnan+O%2E%22">Abu-Yousif, Adnan O.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Palanisami%2C+Akilan%22">Palanisami, Akilan</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Rizvi%2C+Imran%22">Rizvi, Imran</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Xiang+Zheng%22">Xiang Zheng</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Zhiming+Mai%22">Zhiming Mai</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Anbil%2C+Sriram%22">Anbil, Sriram</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Sears%2C+R%2E+Bryan%22">Sears, R. Bryan</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Mensah%2C+Lawrence+B%2E%22">Mensah, Lawrence B.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Goldschmidt%2C+Ruth%22">Goldschmidt, Ruth</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Erdem%2C+S%2E+Sibel%22">Erdem, S. Sibel</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Oliva%2C+Esther%22">Oliva, Esther</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Hasan%2C+Tayyaba%22">Hasan, Tayyaba</searchLink><relatesTo>1,3,4</relatesTo><i> thasan@mgh.harvard.edu</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America%22">Proceedings of the National Academy of Sciences of the United States of America</searchLink>. 3/11/2014, Vol. 111 Issue 10, pE933-E942. 10p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Cancer+treatment%22">Cancer treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Metastasis%22">Metastasis</searchLink><br /><searchLink fieldCode="DE" term="%22Antibody-toxin+conjugates%22">Antibody-toxin conjugates</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+cells%22">Cancer cells</searchLink><br /><searchLink fieldCode="DE" term="%22Chromophores%22">Chromophores</searchLink><br /><searchLink fieldCode="DE" term="%22Fluorescence+microscopy%22">Fluorescence microscopy</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Drug-resistant micrometastases that escape standard therapies often go undetected until the emergence of lethal recurrent disease. Here, we show that it is possible to treat microscopic tumors selectively using an activatable immunoconjugate. The immunoconjugate is composed of self-quenching, near-infrared chromophores loaded onto a cancer cell-targeting antibody. Chromophore phototoxicity and fluorescence are activated by lysosomal proteolysis, and light, after cancer cell internalization, enabling tumor-confined photocytotoxicity and resolution of individual micrometastases. This unique approach not only introduces a therapeutic strategy to help destroy residual drug-resistant cells but also provides a sensitive imaging method to monitor micrometastatic disease in common sites of recurrence. Using fluorescence microendoscopy to monitor immunoconjugate activation and micrometastatic disease, we demonstrate these concepts of "tumor-targeted, activatable photoimmunotherapy" in a mouse model of peritoneal carcinomatosis. By introducing targeted activation to enhance tumor selectively in complex anatomical sites, this study offers prospects for catching early recurrent micrometastases and for treating occult disease. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Proceedings of the National Academy of Sciences of the United States of America is the property of National Academy of Sciences and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=94925778
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1073/pnas.1319493111
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: E933
    Subjects:
      – SubjectFull: Cancer treatment
        Type: general
      – SubjectFull: Metastasis
        Type: general
      – SubjectFull: Antibody-toxin conjugates
        Type: general
      – SubjectFull: Cancer cells
        Type: general
      – SubjectFull: Chromophores
        Type: general
      – SubjectFull: Fluorescence microscopy
        Type: general
    Titles:
      – TitleFull: Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Spring, Bryan Q.
      – PersonEntity:
          Name:
            NameFull: Abu-Yousif, Adnan O.
      – PersonEntity:
          Name:
            NameFull: Palanisami, Akilan
      – PersonEntity:
          Name:
            NameFull: Rizvi, Imran
      – PersonEntity:
          Name:
            NameFull: Xiang Zheng
      – PersonEntity:
          Name:
            NameFull: Zhiming Mai
      – PersonEntity:
          Name:
            NameFull: Anbil, Sriram
      – PersonEntity:
          Name:
            NameFull: Sears, R. Bryan
      – PersonEntity:
          Name:
            NameFull: Mensah, Lawrence B.
      – PersonEntity:
          Name:
            NameFull: Goldschmidt, Ruth
      – PersonEntity:
          Name:
            NameFull: Erdem, S. Sibel
      – PersonEntity:
          Name:
            NameFull: Oliva, Esther
      – PersonEntity:
          Name:
            NameFull: Hasan, Tayyaba
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 03
              Text: 3/11/2014
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-print
              Value: 00278424
          Numbering:
            – Type: volume
              Value: 111
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Proceedings of the National Academy of Sciences of the United States of America
              Type: main
ResultId 1